VITASPRING BIOMEDICAL CO., LTD. (VSBC) Operating margin 2018–2022
VITASPRING BIOMEDICAL CO., LTD. (VSBC) operating margin by fiscal year — reported operating income divided by reported revenue.
20.1%FY2022 · since FY2018: -39.3% → 20.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 20.1% | -151.3 pp |
| FY2021 | 171.4% | +125.7 pp |
| FY2020 | 45.7% | +176.1 pp |
| FY2019 | -130.4% | -91.1 pp |
| FY2018 | -39.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More VSBC financial trends
VSBC RevenueVSBC Net incomeVSBC Net marginVSBC Gross profitVSBC Gross marginVSBC Operating incomeVSBC Operating cash flowVSBC Free cash flowVSBC Capital expendituresVSBC Return on equityVSBC Stock buybacksVSBC Dividends paidVSBC Total assetsVSBC Total liabilitiesVSBC Shareholders’ equityVSBC overview →